Andrew C. Lauck - 05 Nov 2026 Form 4 Insider Report for Strata Critical Medical, Inc. (SRTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Nov 2026, 08:57:50 UTC
Prior SEC filing
03 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melissa M. Tomkiel, as attorney-in-fact for Andrew C. Lauck
Filing notes and source

Key filing fact

Andrew C. Lauck filed Form 4 for Strata Critical Medical, Inc. (SRTA) on 09 Nov 2026.

Key facts

  • This page summarizes Andrew C. Lauck's Form 4 filing for Strata Critical Medical, Inc. (SRTA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Nov 2026, 08:57.

Change

  • Previous filing in this sequence was filed on 03 Aug 2026.
  • Current net transaction value: +$9,998.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970526 Primary reporting owner

LAUCK ANDREW

Relationship
Director
Address
C/O STRATA CRITICAL MEDICAL, INC., 666 THIRD AVENUE, 25TH FLOOR, NEW YORK
Signature
/s/ Melissa M. Tomkiel, as attorney-in-fact for Andrew C. Lauck
Signature date
09 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTA transaction

Class A common stock, $0.0001 par value per share

Purchase

Transaction value
$9,998
Shares
+2,000
Change %
+1.2%
Price
$5.00
Shares after
172,902
Date
05 Nov 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .